Rituximab as monotherapy for the treatment of chronic active antibody‐mediated rejection after kidney transplantation. (30th January 2018) - Muller, Yannick D.; Ghaleb, Nseir; Rotman, Samuel; Vionnet, Julien; Halfon, Matthieu; Catana, Emmanuelle; Golshayan, Déla; Venetz, Jean‐Pierre; Aubert, Vincent; Pascual, Manuel